The problem of genotype and sex differences in life expectancy in transgenic AD mice

Neuroscience and Biobehavioral Reviews

Volumn 57, Issue , 2015, Pages 238-251

  Rae, Eric A ^a   Brown, Richard E ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

3xTg AD; 5xFAD; Alzheimer's; D85; Genotype; JNPL3; Life expectancy; Lifespan; Mice; SAMP8; Sex differences; Tg2576

Indexed keywords

3XTG MOUSE; 5XFAD MOUSE; AGING; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; D85 MOUSE; DISEASE ASSOCIATION; FRAILTY INDEX; GENOTYPE; HUMAN; JNPL3 MOUSE; LIFE EXPECTANCY; MOUSE MODEL; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SENESCENCE ACCELERATED MOUSE; SEX DIFFERENCE; SPECIES DIFFERENCE; SURVIVAL RATE; TG2576 MOUSE; TRANSGENIC MOUSE; ANIMAL; DISEASE MODEL; FEMALE; LONGEVITY; MALE; MOUSE; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; LONGEVITY; MALE; MICE; MICE, TRANSGENIC; SEX FACTORS;

EID: 84952639338     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.09.002     Document Type: Review

References (150)

1. Anisimov V., Arbeev K., Popovich I., Zabezhinski M., Rosenfeld S., Piskunova T., Yashin A. Body weight is not always a good predictor of longevity in mice. Exp. Gerontol. 2004, 39:305-319.
2. Anisimov V., Popovich I., Zabezhinski M. Methods of testing pharmacological drug effects on aging and lifespan in mice. Biol. Aging 2013, 1048:145-160.
3. Anisimov V., Zabezhinski M., Popovich I., Pliss G., Bespalov V., Alexandrov V., Yurova M. Rodent models for the preclinical evaluation of drugs suitable for pharmacological intervention in aging. Expert Opin. Drug Discov. 2012, 7:85-95.
4. Arias E. United States life tables, 2008, National Vital Statistics Report, 61 2012, 1-64.
5. Austad S., Bartke A. Sex differences in longevity and in responses to anti-aging interventions: a mini-review. Gerontology 2015, [Epub ahead of print]. 10.1159/000381472.
6. Bales K. The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update. Expert Opin. Drug Discov. 2012, 7:281-297.
7. Banik A., Brown R., Bamburg J., Lahiri D., Khurana D., Friesland R., Chen W., Ding Y., Mudher A., Padjen A., Mukaetova-Ladinska E., Ihara M., Srivastava S., Padma S., Masters C., Kalaria R., Anand A. Translation of pre-clinical studies into successful clinical trials for Alzheimer's disease: What are the roadblocks and how can they be overcome?. J. Alzheimer's Dis. 2015, 47:815-843.
8. Barger J., Walford R., Weindruch R. The retardation of aging by caloric restriction: its significance in the transgenic era. Exp. Gerontol. 2003, 38:1343-1351.
9. Bartke A. Single-gene mutations and healthy ageing in mammals. Philos. Trans. R. Soc. B 2011, 366:28-34.
10. Bateman R., Chengjie X., Benzinger T., Fagan A., Goate A., Fox N., Morris J. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 2012, 367:795-804.
11. Beery A., Zucker I. Sex bias in neuroscience and biomedical research. Neurosci. Biobehav. Rev. 2011, 35:565-572.
12. Bellizzi D., D'Aquila P., Montesanto A., Corsonello A., Mari V., Mazzei B., Passarino G. Global DNA methylation in old subjects is correlated with frailty. Age 2011, 34:169-179.
13. Bhattacharya S., Haertel C., Maelicke A., Montag D. Galantamine slows down plague formation and behavioural decline in the 5xFAD mouse model of Alzheimer's disease. PLOS ONE 2014, 9:e89454.
14. Billings L., Oddo S., Green K., McGaugh J., LaFerla F. Intraneuronal ABeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005, 45:675-688.
15. Blagosklonny M. Why human lifespan is rapidly increasing: solving "longevity riddle" with "revealed-slow-aging" hypothesis. Aging (Milano) 2010, 2:177-182.
16. Blennow K., Zetterberg H. The application of cerebrospinal fluid diomarkers in early diagnosis of Alzheimer disease. Med. Clin. N. Am. 2013, 97:369-376.
17. Bloss C., Pawlikowska L., Schork N. Contemporary human genetic strategies in aging research. Ageing Res. Rev. 2011, 10:191-200.
18. Bogue M., Peters L., Paigen B., Korstanje R., Yuan R., Ackert-Bicknell C., Chesler E. Accessing data resources in the mouse phenome database for genetic analysis of murine life span and health span. J. Gerontol. A. Biol. Sci. Med. Sci. 2014, pii:glu233 [Epub ahead of print].
19. Bongaarts J. How long will we live. Popul. Dev. Rev. 2006, 32:605-628.
20. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
21. Brayton C., Treuting P., Ward J. Pathobiology of aging mice and GEM: background strains and experimental design. Vet. Pathol. 2012, 49:85-105.
22. Bronikowski A., Flatt T. Aging and its demographic measurement. Nat. Educ. Knowl. 2010, 3:3-9.
23. Brookmeyer R., Corrada M., Curriero F., Kawas C. Survival following a diagnosis of Alzheimer disease. Arch. Neurol. 2002, 59:1764-1767.
24. Brown R., Gunn R., O'Leary T. Visuo-spatial learning and memory in six mouse models of Alzheimer's disease. Genes Brain Behav. 2011, 10:501,. Abstract P-38.
25. Brown R., Hernandez-Lee J., Gunn R., Duffy K. Comparisonn of species-typical and social behaviours in two double-transgenic mouse models of Alzheimer's disease at 12 months of age. Alzheimer's Dement. 2008, 4(Suppl.). Abstract #P1-103.
26. Brown R., Wong A., Feridooni H., Howlett S. Use of the frailty index to compare stages of aging in two mouse models of Alzheimer's disease. J. Frailty Aging 2014, 3:45.
27. Buntink F., De Lepeleire J., Paquay L., Iliffe S., Schoenmakers B. Diagnosing dementia: no easy job. BMC Family Pract. 2011, 12:60.
28. Burrows E., McOmish C., Hannan A. Gene-environment interactions and construct validity in preclinical models of psychiatric disorders. Progr. Neuro-Psychopharmal. Biol. Psychiatry 2010, 35:1376-1382.
29. Buxbaum J. Animal models of human amyloidoses: are transgenic mice worth the time and trouble?. FEBS Lett. 2009, 583:2663-2673.
30. Carlsson C. Lessons learned from failed and discontinued clinical trials for the treatment of Alzheimer's disease: future directions. J. Alzheimer's Dis. 2008, 15:327-338.
31. Chin J. Selecting a mouse model of Alzheimer's disease. Methods Mol. Biol. 2011, 169-189.
32. Chin J., Palop J., Yu G.-Q., Kojima K., Masliah E., Mucke L. Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice. Neurobiol. Dis. 2004, 24:4692-4697.
33. Clegg A., Young J., Iliffe S., Rikkert M., Rockwood K. Frailty in elderly people. Lancet 2013, 381:752-762.
34. Costa D. Causes of improving health and longevity at older ages: a review of the explanations. Genus 2005, 61:21-38.
35. Cummings J., Bruno B., Molinuevo J., Scheltens P. International work group criteria for the diagnosis of Alzheimer disease. Med. Clin. N. Am. 2013, 97:363-368.
36. D'Antona G., Ragni M., Cardile A., Tedesco L., Dossena M., Bruttini F., Nisoli E. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab. 2010, 12:362-372.
37. Demetrius L. Aging in mouse and human systems: a comparative study. N. Y. Acad. Sci. 2006, 1067:66-82.
38. Dubal D., Broestl L., Worden K. Sex and gonadal hormones in mouse models of Alzheimer's disease: what is relevant to the human condition?. Biol. Sex Diff. 2012, 3:24-41.
39. Engelfriet P., Jansen E., Picavet S., Dolle M. Biochemical markers of aging for longitudinal studies in humans. Epidemiol. Rev. 2013, 35:132-151.
40. Feridooni H., Sun M., Rockwood K., Howlett S. Reliability of a frailty index based on the clinical assessment of health deficits in male C57BL/6J mice. J. Gerontol. A. Biol. Sci. Med. Sci. 2014, 70:686-693.
41. Festing M. Inbred Strains of mice. Mouse Genome 1997, 95:519-686.
42. Festing M., Blackmore D. Life span of specified-pathogen-free (MRC category 4) mice and rats. Lab. Anim. 1971, 5:179-192.
43. Flood J., Morley J. Early onset of age-related impairment of aversive and appetitive learning in the SAM-P/8 mouse. J. Gerontol. 1992, 47:52-59.
44. Flurkey K., Currer J., Harrison D. Mouse models in aging research. The Mouse in Biomedical Research, Normative Biology Husbandry Models 2007, vol. III:637-672. American College of Laboratory Animal Medicine (Elsevier), Burlington, MA. 2nd ed.
45. Forster M., Morris P., Sohal R. Genotype and age influence the effect of caloric intake on mortality in mice. FASEB J. 2003, 17:690-692.
46. Fraga M. Genetic and epigenetic regulation of aging. Curr. Opin. Immunol. 2009, 21:446-453.
47. Freude S., Hettich M., Schumann C., Stohr O., Koch L., Kohler C., Schubert M. Neuronal IGF-1 resistance reduced AB accumulation and protects against premature death in a model of Alzheimer's disease. FASEB J. 2009, 23:3315-3324.
48. Garcia-Alloza M., Robbins E., Zhang-Nunes S., Purcell S., Betensky R., Raju S., Frosch M. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol. Dis. 2006, 24:516-524.
49. Gent S., Kleinbongard P., Dammann P., Neuhauser M., Heusch G. Heart rate reduction and longevity in mice. Basic Res. Cardiol. 2015, 110:2.
50. Gimbel D., Nygaard H., Coffey E., Gunther E., Lauren J., Gimbel Z., Strittmatter S. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J. Neurosci. 2010, 30:6367-6374.
51. Gimenez-Llort L., Arranz L., Mate I., De la Fuente M. Gender-specific neuroimmunoendocrine agin in a triple transgenic 3xTg-AD mouse model for Alzhiemer's disease and its relation with longevity. Neuroimmunomodulation 2008, 15:331-343.
52. Goodrick C. Lifespan and the inheritance of longevity of inbred mice. J. Gerontol. 1975, 30:257-263.
53. Haines D.C., Chattopadhyay S., Ward J.M. Pathology of aging B6;129 mice. Toxicol. Pathol. 2001, 29:653-661.
54. Halford R., Russell D. Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3502-3506.
55. Hall A., Roberson E. Mouse models of Alzheimer's disease. Brain Res. Bull. 2012, 88:3-12.
56. Han S., Brunet A. Histone methylation makes in mark on longevity. Trends Cell Biol. 2012, 22:42-49.
57. Hannum G., Guinney J., Zhao L., Zhang L., Hughes G., Sadda S., Zhang K. Genome-wide methylation profiles reveal quantitive views of human aging rates. Mol. Cell 2013, 24:359-367.
58. Harrison D., Strong R., Allison D., Ames B., Astel C., Atamna H., Miller R. Acarbose, 17-a-estradiol, and nordihydroguaiaretic acid extends mouse lifespan preferentially in males. Aging Cell 2014, 13:273-282.
59. Hirata-Fukae C., Li H.-F., Hoe H.-S., Gray A., Minami S., Hamada K., Matsuoka Y. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res. 2008, 1216:92-103.
60. Howlett S., Rockwood K. New horizons in frailty: ageing and the deficit-scaling problem. Age Ageing 2013, 42:416-423.
61. Hsiao K., Borchelt D., Olson K., Johannsdottir R., Kitt C., Yunis W., Carlson G. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 1995, 15:1203-1218.
62. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Cole G. Correlative memory deficits. Abeta elevation, and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
63. Huffman K. The developing, aging neocortex: how genetics and epigenetics influence early developmental patterning and age-related changes. Frontiers Genetics 2012, 3:212. 10.2289/fgene.2012.00212.
64. Huidobro C., Fernandez A., Fraga M. Aging epigenetics: causes and consequences. Mol. Aspects Med. 2013, 34:765-781.
65. Ingram D., Jucker M. Developing mouse models of aging: a consideration of strain differences in age-related behavioural parameters. Neurobiol. Aging 1999, 20:137-145.
66. Ittner L., Ke Y., Delerue F., Bi M., Gladbach A., van Eeresl J., Gotz J. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010, 142:387-397.
67. Jankowsky J., Slunt H., Ratovitski T., Jenkins N., Copeland N., Borchelt D. Co-expression of multiple transgenes in mouse CNS: a comparison on strategies. Biomol. Eng. 2001, 17:157-165.
68. Jaszberenyi M., Rick F., Szalontay L., Block N., Zarandi M., Cai R.-Z., Schally A. Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease. Aging (Milano) 2012, 4:755-767.
69. Jucker M. The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat. Med. 2010, 16:1210-1214.
70. Jucker M., Ingram D. Murine models of brain aging and age-related neurodegenerative diseases. Behav. Brain Res. 1997, 85:1-26.
71. Kammoun S., Gold G., Bouras C., Giannakopoulos P., McGee W., Herrmann F., Michel J. Immediate causes of death of demented and non-demented elderly. Acta Neurol. Scand. 2000, 176:96-99.
72. Khoury J., Toft M., Hickman S., Means T., Terada K., Geula C., Luster A. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 2007, 13:432-438.
73. Kim S., Jazwinski S. Quantitative measures of healthy aging and biological age. Healthy Aging Res. 2015, 4:26.
74. Kivipelto M., Ngandu T., Laatikainen T., Winblad B., Soininen H., Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006, 5:735-741.
75. Kotz J. Phenotypic screening, take two. SciBX 2012, 5:380. 10.1038/scibx.2012.
76. Kumar-Singh S., Dewachter I., Moechars D., Lubke U., De Jonghe C., Ceuterick C., Van Leuven F. Behavioural disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol. Dis. 2000, 7:9-22.
77. Kunstyr I., Leuenberger H.-G. Gerontological data of C57BL/6J mice. I. sex differences in survival curves. J. Gerontol. 1975, 30:157-162.
78. LaFerla F., Green K. Animal models of Alzheimer's disease. Cold Spring Harb. Perspect. Med. 2012, 2:a006320.
79. Lanz T., Carter D., Merchant K. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol. Dis. 2003, 13:246-253.
80. Lee J., Uhlik M., Moxham C., Tomandl D., Sall D. Modern phenotypic drug discovery as a viable, neoclassic pharma strategy. J. Med. Chem. 2012, 55:4527-4538.
81. Levine M. Modeling the rate of senescence: can estimated biological age predict mortality more accurately than chronological age?. J. Gerontol. A. Biol. Sci. Med. Sci. 2013, 68:667-674.
82. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., Hutton M. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 2000, 25:402-405.
83. Li L., Cheung T., Chen J., Herrup K. A comparative study of five mouse models of Alzheimer's disease: cell cycle events reveal new insights into neurons at risk for death. Int. J. Alzheimer's Dis. 2011, 2011:1-10.
84. Liang H., Masoro E., Nelson J., Strong R., McMahan A., Richardson A. Genetic mouse models of extended lifespan. Exp. Gerontol. 2003, 38:1353-1364.
85. Lischka A., Mendelsohn M., Overend T. A systematic review of screening tools for predicting the development of dementia. Can. J. Aging 2012, 31:295-311.
86. Liu H., Graber T., Feruson-Stegall L., Thompson L. Clinically relevant frailty index for mice. J. Gerontol. A. Biol. Sci. Med. Sci. 2014, 69:1485-1491.
87. Maklakov A., Lummaa V. Evolution of sex differences in lifespan and aging: causes and constraints. Bioessays 2013, 35:717-724.
88. Marchese M., Cowan D., Head E., Ma D., Karimi K., Ashthorpe V., Sakic B. Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease. J. Alzheimers Dis. 2014, 39:191-210.
89. Marx J., Brice A., Boston R., Smith A. Incidence rates of spontaneous disease in laboratory mice used at a large biomedical research institution. J. Am. Assoc. Lab. Anim. Sci. 2013, 52:782-791.
90. McCarthy M., Arnold A. Reframing sexual differentiation of the brain. Nat. Neurosci. 2011, 14:677-683.
91. Mitnitski A., Graham J., Mogilner A., Rockwood K. Frailty, fitness and late-life mortality in relation to chronological and biological age. BMC Geriatr. 2002, 27:1.
92. Mitnitski A., Song X., Rockwood K. Assessing biological aging: the origin of deficit accumulation. Biogerontology 2013, 14:709-717.
93. Miyamoto M. Characteristics of age-related behavioural changes in senescence-accelerated mouse SAMP8 and SAMP10. Exp. Gerontol. 1997, 32:139-148.
94. Moechars D., Lorent K., De Strooper B., Dewachet I., Van Leuven F. Expression in brain of amyloid precurson protein mutated in the a-secretase site causes disturbed behaviour, neuronal degeneration and premature death in transgenic mice. EMBO J. 1996, 15:1265-1274.
95. Molsa P., Marttila R., Rinne U. Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurol. Scand. 1986, 74:103-107.
96. Morley J.E. The SAMP8 mouse: a model of Alzheimer disease?. Biogerontology 2002, 3:57-60.
97. Mulvey L., Sinclair A., Selman C. Lifespan modulcation in mice and confounding effects of genetic background. J. Genet. Genomics 2014, 41:497-503.
98. Nadon N. Exploiting the rodent model for studies on the pharmacology of lifespan extension. Aging Cell 2006, 5:9-15.
99. Nadon N., Strong R., Miller R., Nelson J., Javors M., Sharp Z., Harrison D. Design of aging intervention studies: the NIA interventions testing program. Age 2008, 30:187-199.
100. Nathan C., Calingasan N., Nezezon J., Ding A., Lucia M., La Perle K., Beal M. Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J. Exp. Med. 2005, 202:1163-1169.
101. Nelson P., Alafuzoff I., Bigio E., Bouras C., Braak H., Cairns N., Beach T. Correlation of Alzheimer's disease neuropathological changes with cognitive status: a review of the literature. J. Neuropathol. Exp. Neurol. 2012, 71:362-381.
102. Nevalainen T., Kananen L., Marttila S., Jylha M., Heryonen A., Hurme M., Jylhava J. Transcriptomic and epigenetic analyses reveal a gender difference in aging-associated inflammation: the Vitality 90+ study. Age 2015, 37:9814.
103. O'Leary T., Brown R. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Behav. Brain Res. 2009, 201:120-127.
104. Oakley H., Cole S., Logan S., Maus E., Shao P., Craft J., Vassar R. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 2006, 26:10129-10140.
105. Oddo S., Caccampo A., Shepard J., Murphy P., Golde T., Kayed R., LaFerla F. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellualar Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
106. Pallas M. Senescence-accelerated mice P8: a tool to study brain aging and Alzheimer's disease in a mouse model. ISRN Cell Biol. 2012, 2012:1-12.
107. Parks R., Fares E., MacDonald J., Ernst M., Sinal C., Rockwood K., Howlett S. A procedure for creating a frailty index based on deficit accumulation in aging mice. J. Gerontol. A. Biol. Sci. Med. Sci. 2012, 67:217-227.
108. Partridge L., Gems D., Withers D. Sex and death: what is the connection?. Cell 2005, 120:461-471.
109. Pehar M., O'Riordan K., Burns-Cusato M., Andrzejewski M., del Alcazar C., Burger C., Puglielli L. Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death. Aging Cell 2010, 9:174-190.
110. Pettan-Brewer C., Treuting P. Practical pathology of aging mice. Pathobiol. Aging Age-Relat. Dis. 2011, 1. 10.3402/pba.v1i0.7202.
111. Pickering A., Lehr M., Miller R. Lifespan of mice and primates correlates with immunoproteasome expression. J. Clin. Invest. 2015, 125:2059-2068.
112. Porquet D., Casadesus G., Bayod S., Vicente A., Canudas A., Vilaplana J., Valle J. Dietary resveratrol prevents Alzheimer's markers and increases lifespan in SAMP8. Age 2013, 35:1851-1865.
113. Pugh P., Richardson J., Bate S., Upton N., Sunter D. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behav. Brain Res. 2007, 178:18-28.
114. Rao M., McBrayer M., Campbell J., Kumar A., Hashim A., Sershen H., Nixon R. Specific calpain inhibition by calpastatin prevents taupathy and neurodegeneration and restores normal lifespan in tau P301L mice. J. Neurosci. 2014, 34:9222-9234.
115. Ray M., Johnston N., Verhulst S., Trammell R., Thoth L. Identification of markers for imminent death in mice used in longevity and aging research. J. Am. Assoc. Lab. Anim. Sci. 2010, 49:282-288.
116. Rockwood K., Mogilner A., Mitnitski A. Changes with age in the distribution of the frailty index. Mech. Aging Dev. 2004, 125:517-519.
117. Rockwood K., Stadnky K., MacKnight C., McDowell I., Hebert R., Hogan D. A brief clinical instrument to classify frailty in elderly people. Res. Lett. 1999, 353:205-206.
118. Rountree S., Chan W., Pavlik V., Darby E., Doody R. Factors that influence survival in a probable Alzheimer disease cohort. Alzheimer's Res. Ther. 2012, 4:16. 10.1186/alzrt119.
119. Sahin E., Colla S., Liesa M., Moslehi J., Muller F., Guo M., DePinho R. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011, 470:359-365.
120. Sanderson W., Scherbov S. Rethinking age and aging. Popul. Bull. 2008, 63:3-16.
121. Sanderson W., Scherbov S. Remeasuring aging. Science 2010, 329:1287-1288.
122. Schaeffer E., Figueiro M., Gattaz W. Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics 2011, 66:45-54.
123. Selman C., Withers D. Mammalian models of extended healthy lifespan. Philos. Trans. R. Soc. B 2011, 366:99-107.
124. Sharma J., Johnston M., Hossain M. Sex differences in mitochondrial biogenesis determine neuronal death and survivial in response to oxygen glucose deprivation and reoxygenation. BMC Neurosci. 2014, 15:9.
125. Shineman D., Basi G., Bizon J., Colton C., Greenberg B., Hollister B., Fillit H. Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies. Alzheimer's Res. Ther. 2011, 3:28. 10.1186/alzrt90.
126. Singh S., Niemczyk M., Saini D., Sadovov V., Zimniak L., Zimniak P. Distruption of the mGsta4 gene increases life span of C57BL mice. J. Gerontol. A. Biol. Sci. Med. Sci. 2010, 65:14-23.
127. Solomon A., Kivipelto M., Soininen H. Prevention of Alzheimer's disease: moving backward through the lifespan. J. Alzheimer's Dis. 2013, 33:S465-S469.
128. Spindler S. Review of the literature and suggestions for the design of rodent survival studies for the identification of compounds that increase health and life span. Age 2012, 34:111-120.
129. Statistics New Zealand New Zealand period life tables: 2010-12 2013, Retrieved from http://www.stats.govt.nz/browse_for_stats/health/life_expectancy/NZLifeTables_HOTP10-12.aspx.
130. Storer J. Longevity and gross pathology of death in 22 inbred mouse strains. J. Gerontol. 1966, 21:404-409.
131. Sundberg J., Berndt A., Sundberg B., Silva K., Kennedy V., Bronson R., Schofield P. The mouse as a model for understanding chronic diseases of aging: the histopathologic basis of aging in inbred mice. Pathobiol. Aging Age-Relat. Dis. 2011, 1:7179.
132. Swindell W. Dietary restriction in rats and mice: a meta-analysis and review of the evidence for genotype-dependent effects on lifespan. Ageing Res. Rev. 2012, 11:254-270.
133. Swindell W., Enstrud K., Cawthon P., Cauley J., Cummings S., Miller R. Indicators of "healthy aging" in older women (65-69 years of age). A data-mining approach based on prediction of long-term survivial. BMC Geriatr. 2010, 10:55.
134. Swinney D., Anthony J. How were new medicines discovered?. Nat. Rev. Drug Discov. 2011, 10:507-519.
135. Takemura M., Nakamura S., Akiguchi I., Ueno M., Oka N., Ishikawa S., Takeda T. Beta/A4 protein like immunoreactive granular structures in the brain of senescence-accelerated mouse (SAM). Am. J. Pathol. 1993, 142:1887-1897.
136. Tatar M. Can we develop geneticall tractable models to asses healthspan (rather than life span) in animal models?. J. Gerontol. A. Biol. Sci. Med. Sci. 2009, 64:161-163.
137. Tower J. Sex-specific regulation of aging and apoptosis. Mech. Aging Dev. 2006, 127:705-718.
138. Umezawa M., Hanada K., Naiki H., Chen W., Hosokawa M., Hosono M., Takeda T. Effects of dietary restriction on age-related immune dysfunction in the senescence accelerated mouse (SAM). J. Nutr. 1990, 120:1393-1400.
139. Vanhooren V., Libert C. The mouse as a model organism in aging research: usefulness, pitfalls and possibilities. Ageing Res. Rev. 2013, 12:8-21.
140. VonBohlen und Halbach O., Unsicker K. Morphological alteration in the amygdala and hippocampus if mice during ageing. Eur. J. Neurosci. 2002, 16:2434-2440.
141. Weintraub S., Wicklund A., Salmon D. The neuropsychological profile of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012, 2:a006171.
142. Westmark C., Westmark P., Beard A., Hildebrandt S., Malter J. Seizure susceptibility and mortality in mice that over express amyloid precursor protein. Int. J. Clin. Exp. Pathol. 2008, 1:157-168.
143. Whitehead J., Hildebrand B., Sun M., Rockwood M., Rose R., Rockwood K., Howlett S. A clinical frailty index in aging mice: comparisons with frailty index data in humans. J. Gerontol. A. Biol. Sci. Med. Sci. 2014, 69:612-632.
144. Wong A., Brown R. Age-related changes in visual acuity, learning and memory in C57BL/6J and DBA/2J mice. Neurobiol. Aging 2007, 28:1577-1593.
145. Workman A., Charvet C., Clancy B., Darlington R., Finlay B. Modeling transformations of neurodevelopmental sequences across mammalian species. J. Neurosci. 2013, 33:7368-7383.
146. Xie J., Brayne C., Matthews F. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ 2008, 336:258-262.
147. Yuan R., Peters L., Paigen B. Mice as a mammalian model for research on the genetics of aging. ILAR J. 2011, 52:4-15.
148. Yuan R., Tsaih S.-W., Petkova S., de Evikova C., Xing S., Marion M., Paigen B. Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF-1 levels. Aging Cell 2009, 8:277-287.
149. Zhang B., Higuchi M., Yoshiyama Y., Ishihara T., Forman M., Martinez D., Lee V. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative taupathology. Neurobiol. Dis. 2004, 24:4657-4667.
150. Zhang Y., Bokov A., Gelfond J., Soto V., Ikeno Y., Hubbard G., Fischer K. Rapamycin extends life and health in C57BL/6 mice. J. Gerontol. A. Biol. Sci. Med. Sci. 2014, 69:119-130.